Search

Linda Li is a senior data analyst for the Women’s Health Policy team at KFF, where she analyzes women’s health care experiences, utilization, spending, and affordability. Prior to joining KFF, Dr. Li worked as a data analyst in health policy and economics research. She holds a Master of Public Health degree from…

This tracker provides data on global COVID-19 cases and deaths by country, region, and income-level. Additionally, the tracker reports current closure, economic, and health system policy responses to the COVID-19 pandemic globally. This tracker will be updated as new data are available.

This brief examines the implications of rising prescriptions for costly GLP-1 drugs for state Medicaid programs as more states consider covering the drugs for weight loss. It examines recent trends in Medicaid prescriptions and gross spending on GLP-1s, and explores the potential implications of expanding coverage obesity drugs for Medicaid programs.